Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2022

Stockholders' Equity

Schedule of fair value of stock option awards valuation assumptions

		Weighted		Weighted
		Average		Average	Aggregate
	Number of	Exercise		Remaining	Intrinsic
	Shares	Price		Term	Value
Balance as of December 31, 2021	4,560	$	6.29	3.07	$	2,670
Granted	627		4.19
Exercised	(308)		1.02
Forfeited	(191)		6.37
Expired	(453)		7.48
Balance as of June 30, 2022	4,235		6.23	3.74		177
Expected to vest at June 30, 2022	4,235		6.23	3.74		177
Exercisable at June 30, 2022	3,288		6.19	2.19		177

Schedule of the restricted stock unit activity

		Weighted Average Grant-
	Shares	Date Fair Value
Outstanding as of December 31, 2021	5,235	$	8.88
Granted	5,226		3.95
Vested	(3,728)		8.48
Forfeited	(775)		6.47
Outstanding as of June 30, 2022	5,958	$	5.12

Schedule of Stock-Based Compensation Expense

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
Cost of revenue, excluding depreciation and amortization	$	2,695	$	113	$	3,155	$	155
Sales and marketing		1,391		32		2,113		61
General and administrative		3,782		47		6,380		101
Research and development		3,416		17		3,576		30
Total	$	11,284	$	209	$	15,224	$	347